Reversible Parkinsonism With Recovery of 123 I-Ioflupane DAT‑SPECT After Treating Rheumatoid Meningitis.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 41686485.
- Also identified by DOI 10.1097/RLU.0000000000006361.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We report reversible parkinsonism in rheumatoid meningitis with normalization of 123 I-ioflupane DAT-SPECT after immunotherapy. A previously independent 42-year-old man presented with fever, encephalopathy, focal seizures, and akinetic-rigid parkinsonism. MRI showed pachy/leptomeningeal enhancement with sulcal FLAIR hyperintensity; CSF revealed lymphocytic pleocytosis and elevated protein with negative infectious studies. High-dose intravenous methylprednisolone followed by taper led to rapid improvement. Baseline DAT-SPECT showed reduced striatal uptake, which recovered on follow-up in parallel with symptom resolution and reductions in intrathecal anti-CCP index and CSF IL-6, supporting autoimmune, reversible presynaptic dopaminergic dysfunction.
Medical subject headings
- Tomography, Emission-Computed, Single-Photon
- Nortropanes
- Parkinsonian Disorders
- Meningitis
- Dopamine Plasma Membrane Transport Proteins
- Recovery of Function